FDA to Disclose Staff Review of Merck Covid-19 Pill

fda to disclose staff review of merck covid 19 pill

Sumary of FDA to Disclose Staff Review of Merck Covid-19 Pill:

  • Molnupiravir, and another experimental antiviral from Pfizer Inc. PFE -0.37% that is also under FDA review, promise to fill a big gap in Covid-19 treatment for a pill that people could easily take at home to keep them out of the hospital.
  • How molnupiravir interferes with RNA replication How viral reproduction works New RNA is assembled by stringing together blocks of chemical units called bases.
  • molnupiravir The shape of the molnupiravir molecule resembles one of these bases.
  • When the drug enters an infected cell, it is incorporated into the growing viral RNA strand.
  • 3. Once an RNA molecule is complete, it gets packaged into a new viral coating and exported from the cell.
  • How viral reproduction works The virus infiltrates a patient’s cells.
  • Once an RNA molecule is complete, it gets packaged into a new viral coating and exported from the cell.
  • How molnupiravir interferes with RNA replication New RNA is assembled by stringing together blocks of chemical units called bases.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close